Diagnosis of atrophic body gastritis in Chinese patients by measuring serum pepsinogen

Chinese Journal of Digestive Diseases

Volumn 5, Issue 1, 2004, Pages 22-27

  Wu, Kai Chun ^a   Li, Hong Tao ^a   Qiao, Tai Dong ^a   Li, Cai Ning ^a   Ji, Wan Sheng ^a   Tian, Feng Qi ^a   Wang, Xin ^a   Wang, Biao Luo ^a   Miao, Ji Yan ^a   Ding, Jie ^a   Fan, Dai Ming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Atrophic gastritis; Diagnosis; GPII ratio; Helicobacter pylori; Pepsinogen; PGI

Indexed keywords

BACTERIUM ANTIBODY; BIOLOGICAL MARKER; IMMUNOGLOBULIN G ANTIBODY; PEPSINOGEN; PEPSINOGEN I; PEPSINOGEN II;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BLOOD SAMPLING; CALCULATION; CHINESE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DYSPEPSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH MUCOSA;

AGED; ANTIBODIES, BACTERIAL; BIOLOGICAL MARKERS; BIOPSY; FEMALE; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PEPSINOGENS; PYLORIC ANTRUM; ROC CURVE; SENSITIVITY AND SPECIFICITY;

CONTENT-BASED SUBSCRIPTION; E-SERVICE; LOGARITHMIC CONSTRUCT INTERVALS (LCI); SECONDARY-STORAGE BASED INDEXES;

ALGORITHMS; AUTOMATIC INDEXING; COMPUTATIONAL COMPLEXITY; COMPUTER SIMULATION; COSTS; SENSORS; VECTORS; WORLD WIDE WEB;

ELECTRONIC COMMERCE;

EID: 14244263142     PISSN: 14439611     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1443-9573.2004.00148.x     Document Type: Article

References (21)

1. Sipponen P, Härkönen M, Alanko A et al. Diagnosis of atrophic gastritis from a serum sample. Clin Lab 2002; 48: 505-15.
2. Suovaniemi O, Härkönen M, Paloheimo L et al. Diagnosis of atrophic gastritis from a serum sample. Jordan Med J 2002; 36: 117-21.
3. Correa P. Human gastric carcinogenesis: Multistep and multifactorial process. Cancer Res 1992; 52: 6735-42.
4. Mardh E, Mardh S, Mardh B et al. Diagnosis of gastritis by means of a combination of serological analyses. Clin Chim Acta 2002; 320: 17-27.
5. Broutet N, Plebani M, Sakarovitch C et al. Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics. Br J Cancer 2003; 88: 1239-47.
6. Miki K. Serum pepsinogen I/II ratio test. Nippon Rinsho 2003; 61: 92-5.
7. Korstanje A, den Hartog G, Biemond I et al. The serological gastric biopsy: A non-endoscopical diagnostic approach in management of the dyspeptic patient: Significance for primary care based on a survey of the literature. Scand J Gastroenterol Suppl 2002; 236: 22-6.
8. So JB-Y, Yeoh K-G, Moochala S et al. Serum pepsinogen levels in gastric cancer patients and their relationship with Helicobacter pylori infection: A prospective study. Gastric Cancer 2002; 5: 228-32.
9. Zagari RM, Nicolini G, Casanova S et al. Diagnosis of atrophic gastritis in the general population based upon a combination of three non-invasive tests. Gut 2002; 51(Suppl 11): A39.
10. Dixon FM, Genta RM, Yardley JH et al. Classification and grading of gastritis: The updated Sydney System. Am J Surg Pathol 1996; 20: 1161-81.
11. Sipponen P, Ranta P, Helske T et al. Serum levels of amidated gastrin-17 and pepsinogen I in atrophic gastritis: An observational case-control study. Scand J Gastroenterol 2002; 37: 785-91.
12. He X, Jiang L, Fu B, Zhang X. Relationship between interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms and susceptibility to gastric cancer. Zhonghua Yi Xue Za Zhi 2002; 82: 685-8.
13. Figueiredo C, Machado JC, Pharoah P et al. Helicobacter pylori and interleukin 1 genotyping: An opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002; 94: 1680-7.
14. El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402.
15. Varis K, Sipponen P, Laxén F et al. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Scand J Gastroenterol 2000; 35: 950-6.
16. Varis K, Kekki M, Härkönen M et al. Serum pepsinogen I and serum gastrin in the screening of atrophic pangastritis with high risk of gastric cancer. Scand J Gastroenterol 1991; 186: 117-23.
17. Kitahara F, Kobayashi K, Sato T et al. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 1999; 44: 693-697.
18. Wong BCY, Yin Y, Berg DE et al. Distribution of distinct vacA, cagA and iceA alleles in Helicobacter pylori in Hong Kong. Helicobacter 2001; 6: 317-24.
19. Leung WK, Ng EKW, Chan FKL et al. Evaluation of three commercial enzyme-linked immunosorbent assay kits for diagnosis of Helicobacter pylori in Chinese patients. Diagn Microbiol Infect Dis 1999; 34: 13-17.
20. Marchildon PA, Sugiyama T, Fukuda Y et al. Evaluation of the effects of strain-specific antigen variation on the accuracy of serologic diagnosis of Helicobacter pylori infection. J Clin Microbiol 2003; 41: 1480-5.
21. Axon AT. Are all helicobacters equal? Mechanisms of gastroduodenal pathology and their clinical implications. Gut 1999; 45(Suppl 1): 1-4.